Follicular lymphoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Follicular lymphoma}} | {{Follicular lymphoma}} | ||
{{CMG}} | |||
==Overview== | ==Overview== | ||
==Laboratory Findings== | |||
Laboratory findings consistent with the diagnosis of follicular lymphoma includes | |||
* Histological confirmation by centroblasts and centrocytes. | |||
* Immunophenotyping using flow cytometry to detect immunophenotypes like CD20+, CD10+, BCL2+, CD23+/-, CD43-, CD5-, CCND1-, CD10-, BCL2- and BCL6+ | |||
* Immunohistochemistry for Ki-67,Aggressive clinical behavior is in association with low-grade follicular lymphoma with a high proliferation index. ( determined by Ki-67 immunostaining) * Molecular genetic analysis for BCL2 rearrangement | |||
* Cytogenetics or FISH for t(14;18) | |||
==References== | ==References== |
Revision as of 20:26, 22 August 2015
Follicular lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Follicular lymphoma laboratory findings On the Web |
American Roentgen Ray Society Images of Follicular lymphoma laboratory findings |
Risk calculators and risk factors for Follicular lymphoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
Laboratory findings consistent with the diagnosis of follicular lymphoma includes
- Histological confirmation by centroblasts and centrocytes.
- Immunophenotyping using flow cytometry to detect immunophenotypes like CD20+, CD10+, BCL2+, CD23+/-, CD43-, CD5-, CCND1-, CD10-, BCL2- and BCL6+
- Immunohistochemistry for Ki-67,Aggressive clinical behavior is in association with low-grade follicular lymphoma with a high proliferation index. ( determined by Ki-67 immunostaining) * Molecular genetic analysis for BCL2 rearrangement
- Cytogenetics or FISH for t(14;18)